GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Market Cap

Glycorex Transplantation AB (NGM:GTAB B) Market Cap : kr171.90 Mil (As of Jul. 13, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Glycorex Transplantation AB's share price for the quarter that ended in Mar. 2025 was kr2.01. Glycorex Transplantation AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 82.12 Mil. Therefore, Glycorex Transplantation AB's market cap for the quarter that ended in Mar. 2025 was kr165.07 Mil.

Glycorex Transplantation AB's quarterly market cap declined from Sep. 2024 (kr161.00 Mil) to Dec. 2024 (kr150.66 Mil) but then increased from Dec. 2024 (kr150.66 Mil) to Mar. 2025 (kr165.07 Mil).

Glycorex Transplantation AB's annual market cap declined from Dec. 2022 (kr302.80 Mil) to Dec. 2023 (kr97.86 Mil) but then increased from Dec. 2023 (kr97.86 Mil) to Dec. 2024 (kr150.66 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Glycorex Transplantation AB's Enterprise Value for Today is kr163.10 Mil.


Glycorex Transplantation AB Market Cap Historical Data

The historical data trend for Glycorex Transplantation AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Market Cap Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 849.32 686.84 302.80 97.86 150.66

Glycorex Transplantation AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.78 77.55 161.00 150.66 165.07

Competitive Comparison of Glycorex Transplantation AB's Market Cap

For the Biotechnology subindustry, Glycorex Transplantation AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glycorex Transplantation AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Glycorex Transplantation AB's Market Cap falls into.


;
;

Glycorex Transplantation AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Glycorex Transplantation AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=kr2.04*73.854
=kr150.66

Glycorex Transplantation AB's Market Cap for the quarter that ended in Mar. 2025 is calculated as

Market Cap (Q: Mar. 2025 )=Share Price (Q: Mar. 2025 )*Shares Outstanding (EOP) (Q: Mar. 2025 )
=kr2.01*82.122
=kr165.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glycorex Transplantation AB  (NGM:GTAB B) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Glycorex Transplantation AB Market Cap Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Glycorex Transplantation AB Business Description

Traded in Other Exchanges
Address
Solvegatan 41, Lund, SWE, 223 70
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines